Cardlytics, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities | ||
| Net Loss | $(95,238) | $(173,715) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Credit loss expense | 1,782 | 3,980 |
| Depreciation and amortization | 19,039 | 19,749 |
| Amortization of financing costs charged to interest expense | 1,194 | 1,235 |
| Amortization of right-of-use assets | 1,789 | 1,627 |
| Gain on disposal or divestiture | (4,831) | — |
| Gain on debt extinguishment | — | (13,017) |
| Stock-based compensation expense | 22,617 | 31,694 |
| Impairment of goodwill and intangible assets | 58,843 | 131,595 |
| Change in contingent consideration | 102 | 110 |
| Other non-cash income, net | (6,251) | (4,136) |
| Change in operating assets and liabilities: | ||
| Accounts receivable | 14,808 | 12,909 |
| Prepaid expenses and other assets | (230) | (229) |
| Accounts payable | (193) | 820 |
| Other accrued expenses | 1,762 | (3,192) |
| Partner Share liability | (10,920) | (18,330) |
| Consumer Incentive liability | (7,993) | (2,903) |
| Net cash used in operating activities | (3,720) | (11,803) |
| Investing activities | ||
| Acquisition of property and equipment | (455) | (1,439) |
| Capitalized software development costs | (12,770) | (13,423) |
| Business divestiture and acquisitions, net of cash acquired | 200 | 202 |
| Net cash used in investing activities | (13,025) | (14,660) |
| Financing activities | ||
| Proceeds from issuance of debt | 50,000 | 172,500 |
| Settlement of contingent consideration | (5,000) | (14,167) |
| Principal payment of debt | (50,000) | (199,291) |
| Proceeds from termination of capped calls related to convertible notes | — | 115 |
| Proceeds from issuance of common stock | — | 48,634 |
| Equity issuance costs | — | (309) |
| Debt issuance costs | (105) | (5,836) |
| Net cash (used in) provided by financing activities | (5,105) | 1,646 |
| Effect of exchange rates on cash and cash equivalents | 217 | (25) |
| Net decrease in cash and cash equivalents | (21,633) | (24,842) |
| Cash and cash equivalents — Beginning of period | 65,594 | 91,830 |
| Cash and cash equivalents — End of period | $43,961 | $66,988 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $4,780 | $2,453 |
| Amounts accrued for property and equipment | $14 | $20 |
| Amounts accrued for capitalized software development costs | $141 | $203 |
| Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) | $— | $27,451 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.